Ideaya Biosciences (IDYA) said late Thursday it closed its underwritten public offering, raising about $345 million in gross proceeds before underwriting discounts, commissions and other offering expenses.
The offering included 7.22 million shares of common stock priced at $27 per share and pre-funded warrants to purchase 5.56 million shares of common stock priced at $26.9999 per warrant.
The total also reflects the underwriters' full exercise of an option to purchase an additional 1.67 million shares of common stock.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments